Regeneron Trial Shows Trevogrumab Prevents Muscle Loss With GLP-1 Weight Loss
Regeneron's Phase 2 trial indicated that trevogrumab can prevent muscle loss in patients undergoing GLP-1 weight loss therapy.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.